232 related articles for article (PubMed ID: 32751497)
41. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
Liu X; Zhang X; Zhan Q; Brock MV; Herman JG; Guo M
Cancer Biol Ther; 2012 Oct; 13(12):1152-7. PubMed ID: 22892849
[TBL] [Abstract][Full Text] [Related]
42. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
43. Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
Watanabe K; Amano Y; Ishikawa R; Sunohara M; Kage H; Ichinose J; Sano A; Nakajima J; Fukayama M; Yatomi Y; Nagase T; Ohishi N; Takai D
Cancer Med; 2015 Oct; 4(10):1573-82. PubMed ID: 26256448
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic regulation of ANKRD18B in lung cancer.
Liu WB; Han F; Jiang X; Yin L; Chen HQ; Li YH; Liu Y; Cao J; Liu JY
Mol Carcinog; 2015 Apr; 54(4):312-21. PubMed ID: 24249358
[TBL] [Abstract][Full Text] [Related]
45. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
46. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
[TBL] [Abstract][Full Text] [Related]
47. RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells.
Chen H; Yang T; Lei Z; Wang L; Yang H; Tong X; Yang WT; Zhao J; Gu Y; Chen Y; Zhang HT
Lung Cancer; 2015 Oct; 90(1):32-40. PubMed ID: 26238425
[TBL] [Abstract][Full Text] [Related]
48. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
49. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
Lin SH; Wang J; Saintigny P; Wu CC; Giri U; Zhang J; Menju T; Diao L; Byers L; Weinstein JN; Coombes KR; Girard L; Komaki R; Wistuba II; Date H; Minna JD; Heymach JV
BMC Genomics; 2014 Dec; 15(1):1079. PubMed ID: 25486910
[TBL] [Abstract][Full Text] [Related]
50. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
[TBL] [Abstract][Full Text] [Related]
51. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
52. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
53. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
[TBL] [Abstract][Full Text] [Related]
55. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
[TBL] [Abstract][Full Text] [Related]
56. microRNA-9 selectively targets LMX1A to promote gastric cancer cell progression.
Zhang X; Qian Y; Li F; Bei S; Li M; Feng L
Biochem Biophys Res Commun; 2018 Oct; 505(2):405-412. PubMed ID: 30262143
[TBL] [Abstract][Full Text] [Related]
57. The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells.
Kucuksayan H; Akca H
Tumour Biol; 2017 Sep; 39(9):1010428317706212. PubMed ID: 28937318
[TBL] [Abstract][Full Text] [Related]
58. Roles of miR-200 family members in lung cancer: more than tumor suppressors.
Liu C; Hu W; Li LL; Wang YX; Zhou Q; Zhang F; Song-Yang YY; Zhu W; Sun CC; Li DJ
Future Oncol; 2018 Nov; 14(27):2875-2886. PubMed ID: 30208739
[TBL] [Abstract][Full Text] [Related]
59. Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.
Liu C; Lv D; Li M; Zhang X; Sun G; Bai Y; Chang D
Int J Oncol; 2017 Jun; 50(6):2079-2090. PubMed ID: 28440397
[TBL] [Abstract][Full Text] [Related]
60. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]